Clinical Trials Logo

Poisoning clinical trials

View clinical trials related to Poisoning.

Filter by:

NCT ID: NCT04050267 Completed - Clinical trials for Nitrous Oxide Poisoning

Effects of Low Concentrations of Nitrous Oxide

Start date: April 25, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to test the effects of low concentrations of nitrous oxide on cognitive functions and reaction time in human.

NCT ID: NCT04036708 Completed - Malnutrition Clinical Trials

Caregiver Training to Prevent Konzo Disease in Children in Democratic Republic of Congo (DRC)

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The proposed research adapted the caregiver training and child neurodevelopmental assessment capacity that the PI previously built in Uganda beginning in 2008, to a community-based intervention model for the prevention of konzo in the Democratic Republic of Congo.

NCT ID: NCT03953248 Completed - Toxicity Clinical Trials

L-Carnitine as an Adjuvant Treatment in Acute Phosphide Poisoning (LC)

Start date: January 2016
Phase: Early Phase 1
Study type: Interventional

The aim of this study was to evaluate efficacy and safety of Alpha Lipoic Acid(ALA) as an adjuvant in the management of patients with acute phosphide poisoning.

NCT ID: NCT03926494 Completed - Coma Clinical Trials

Carbon Monoxide-induced Coma: Prognostic Factors

Coma-CO
Start date: May 1, 2019
Phase:
Study type: Observational

The primary objective of the study is to determine prognostic factors for hospital-mortality following carbon monoxide (CO)-induced coma. The secondary objective is to determine prognostic factors of CO related cognitive sequelae, at the time of hospital discharge.

NCT ID: NCT03879356 Completed - Clinical trials for Using New Protocol to Prove the Role of N-acetyl Cysteine and Adequate Supportive Measures in Aluminum Phosphide Poisoning

Supportive Measures in Treatment of Aluminum Phosphide Poisoning

Start date: January 1, 2016
Phase: Phase 4
Study type: Interventional

Aluminum phosphide poisoning (ALP) is a global public health problem, and self-poisoning accounts for one-third of the world's suicide rate. In fact, in some parts of developing countries, pesticide poisoning causes more deaths than infection. ALP is very common in our government and the prognosis of the cases is usually so bad. Toxicity by ALP is caused by the liberation of phosphine gas, which causes cell hypoxia due to inhibition of oxidative phosphorylation leading to circulatory failure.

NCT ID: NCT03826537 Completed - Tutin Poisoning Clinical Trials

A Study of How Tutin and Hyenanchin, Two Toxins Found in Honey, Are Absorbed and Processed by the Body

Start date: January 2012
Phase: N/A
Study type: Interventional

Honey available in New Zeland can contain the toxins tutin and hyenanchin. Tutin is produced by several plants native to New Zealand. Bees collect honeydew contaminated with tutin and hyenanchin for honey production. Honey contaminated with high levels of tutin has caused cases of poisoning in New Zealand since the 1800s, with the most recent outbreak in 2008. The study aims to find out how tutin and hyenanchin are absorbed and processed by the body. This information will help the FSANZ give guidance on acceptable levels of tutin and hyenanchin in honey. About 6 healthy men will each take a single dose of honey containing known concentrations of tutin and hyenanchin. This dose level is similar to what someone who eats a lot of honey would have, if the honey contained the maximum level of tutin allowed under the Food Standards Code. Blood tests to measure tutin and hyenanchin levels will be taken at certain times after dosing, and any side effects will be recorded.

NCT ID: NCT03726632 Completed - Intoxication Clinical Trials

Causality of Poisoning of the Elderly: Prospective Study Based on Data From the Poison Control Centre of Bordeaux

GERIATOX
Start date: April 3, 2017
Phase:
Study type: Observational

Elderly is often associated with social, physiological and psychic changes. However, no study has examined accidental poisoning-induced changes. The objective of the study is to identify and analyze the various causes of potentially toxic accidental exposure of the elderly to determine preventable causes and propose prevention strategies.

NCT ID: NCT03708250 Completed - Clinical trials for Button Battery Poisoning

PilBouTox® Project: Button Battery Poisoning From Data Collected by French Poison Control Centres

PILBOUTOX
Start date: June 1, 2016
Phase:
Study type: Observational

Button batteries are found in all householders and can be responsible for poisoning, in particular in children. Unexpected complications and death in children who have ingested button battery have been published for over twenty years in medical literature. There are many questions related to the treatment that remain unanswered, because some data are missing in previously published studies. The main objective of this study is to precisely describe poisoning cases by button battery in order to propose a better management

NCT ID: NCT03669848 Completed - Clinical trials for Carbon Monoxide Poisoning

Is Transcutaneous Carbon Monoxide Saturation of E-cigarette Users Comparable to That of Smokers?

COVAP
Start date: September 12, 2018
Phase:
Study type: Observational

Suspicions of carbon monoxide poisoning that lead to the treatment of victims are numerous. Measurement of transcutaneous carbon monoxide saturation (SpCO) is a useful diagnostic and triage tool for victims and the toxic threshold is clearly defined for both non-smokers (SpCO> 5%) and smokers ( SpCO> 10%). Currently, the use of e-cigarettes is democratizing. Unfortunately, the threshold for toxic SpCO is not defined for this patient profile. The risk is treating in excess or worse than underestimating carbon monoxide poisoning in e-cigarette users who would be exposed to carbon monoxide exposure.

NCT ID: NCT03658902 Completed - Botulism; Poisoning Clinical Trials

Retrospective Epidemiological Study on Botulism in Intensive Care Units in France

BotuREA
Start date: January 1, 2000
Phase:
Study type: Observational

Botulism poisoning is a rare but serious illness. Because of it's low incidence, it is not well known by physicians. Most studies describing botulism date back to the last century and do not take into account recent advances in intensive care. The objective of this study is to describe the clinical course, interventions and outcomes of patients with severe botulism poisoning requiring a hospitalisation in an intensive care or high dependancy unit.